Resources/
Press Releases
Press Releases
September 22, 2025
Press Release: PHIL Launches Direct-to-Patient 2.0 Platform to Transform Access, Affordability, and Adherence in Pharma
PHIL, a leader in patient access solutions for the life sciences industry, today announced the launch of PHIL Direct, its Direct-to-Patient (DTP) 2.0 platform, designed to help pharmaceutical brands meet evolving patient expectations while navigating affordability, compliance, and policy pressures.
July 8, 2025
Press Release: PHIL Secures $60M Growth Capital from K2 HealthVentures to Accelerate AI Integration
Phil, a leading software-driven pharmaceutical commercialization platform, today announced a $60 million growth debt financing from K2 HealthVentures (K2HV), a healthcare and life sciences-focused investment firm. The funding will accelerate the integration of artificial intelligence across Phil's platform and support continued customer expansion across a broad range of therapeutic areas.
July 6, 2023
Phil and RedHill Biopharma Partner to Increase Access to Talicia®
Talicia® is indicated for the treatment of Helicobacter pylori infection in adults Patients can now access RedHill’s Talicia® via the PhilRx Platform SAN FRANCISCO, Calif. – July 6, 2023 – Phil Inc., a patient access platform company that revolutionizes life science product commercialization, today announced an agreement with RedHill Biopharma (Nasdaq: RDHL) (‘RedHill’) to make its medication Talicia® (omeprazole magnesium, amoxicillin, and rifabutin) available via the PhilRx Patient Access Platform. The PhilRx Patient Access Platform provides end-to-end visibility into the entire prescription life cycle, starting the moment the physician writes a prescription
June 6, 2023
Phil and Teva Pharmaceuticals Launch New Program to Improve Access
SAN FRANCISCO, Calif. – June 6, 2023 – Phil Inc., a patient access platform company that revolutionizes life science product commercialization, today announced an agreement with Teva Pharmaceuticals that will make Digihaler® products available for prescription using the PhilRx Patient Access Platform. Teva’s Digihaler system is the first and only smart inhaler system that can provide objective inhaler data to help patients and their doctors have informed treatment discussion in support of asthma management
Ready to learn more?
Our consultants will work with you to analyze your current channel strategy and make recommendations for how to improve patient access and increase the percentage of scripts getting covered by insurance.
Create a Path to Commercial Success
Our expert team can build a tailored access program that drives your brand goals.
Our Solutions
About Us
